With the acceleration of the development of the biopharmaceutical industry, pharmaceutical companies are also using innovation to help

Biomedicine is not only an important engine for economic development, but also a major livelihood project
.
It is understood that in recent years, with the support of national policies, many places have also vigorously developed the biomedical industry
.
For example, in recent years, Jiangsu Province has taken biomedicine as an important foundation for improving Jiangsu's economic resilience
.
Recently, the Jiangsu Provincial Market Supervision Bureau, the Provincial Food and Drug Administration, and the Provincial Intellectual Property Office also jointly issued the "Opinions on Deepening Reform and Innovation to Promote the High-Quality Development of the Biopharmaceutical Industry" (referred to as the "Opinions")
.
The development of China's biomedical industry is accelerating (picture source; pharmaceutical network) The "Opinions" clearly stated that it will accelerate the construction of a more innovative, higher value-added, safer and more reliable biomedical industry chain supply chain
.
By 2024, the basic capabilities of the province's biomedical industry and the modernization level of the industrial chain will continue to improve, the proportion of innovative drugs and high-end medical devices with independent intellectual property rights will increase significantly, and a number of key core technologies that restrict the high-quality development of the biomedical industry will be overcome.
To build a batch of world-class biomedical companies.
.
.
In addition to Jiangsu Province, the Hainan Provincial Food and Drug Administration has also issued the "Notice on Further Optimizing Services to Support the High-Quality Development of the Biomedical Industry", and a total of 12 optimization service measures have been introduced to promote the industry Agglomeration development, encouragement to undertake the production and transfer of drugs and medical devices, facilitating registration inspection and clinical evaluation, and optimizing review and approval are four aspects to continuously optimize the business environment and support the high-quality development of Hainan's biomedical industry
.
The above-mentioned provinces are just a microcosm of many places aimed at boosting the development of the biomedical industry
.
The industry predicts that in the future, with the intensification of aging, the continuous upgrading of consumption, and the advancement of a series of favorable policies, the scale of the entire biomedical industry market will continue to expand and its development will accelerate toward high quality
.
It is worth mentioning that with the vigorous development of the biopharmaceutical industry, analysis believes that China's biopharmaceutical equipment industry will also usher in huge market opportunities
.
It should be noted that from the current point of view, while my country's biopharmaceutical equipment is developing continuously, the lack of mid-to-high-end market is serious, the overall innovation capability of the industry is still weak, and the product quality is also uneven.
The high-quality development of the industry is restricted
.
For example, pharmaceutical companies have a low degree of trust in domestic biopharmaceutical equipment, causing many companies to rely on imported equipment
.
Earlier, the head of a domestic biopharmaceutical company said in an interview with the media that 95% of the company's biopharmaceutical equipment is imported
.
It is reported that in order to better promote the development of the biomedical industry and expand the development space, a large number of local biopharmaceutical equipment companies have begun to vigorously innovate and upgrade related equipment, and some new technologies and equipment are constantly emerging
.
For example, in order to reduce the loss during operation, some companies have specially designed and produced bioprocess bag testers to improve the production efficiency of biopharmaceutical companies
.
According to the research and development personnel, the bioprocess bag tester uses a technology to test the bioprocess bag at the point of use in a non-destructive manner
.
This method has been verified in multiple directions and can be operated fully automatically
.
In terms of avoiding the risks caused by manual operation, the bioprocess bag tester will be an effective choice for enterprises
.
In addition, the raw liquid preparation and engineering capability output of biomedicine is the track for the rapid growth of the market demand for innovative drugs in China and even the world in the future
.
Therefore, some companies have also planned to focus on the development of pharmaceutical liquid dispensing systems, intelligent logistics systems, and pharmaceutical R&D service areas for bio-innovative drugs
.
In general, the birth of new biopharmaceutical equipment and technology is of great significance to the development and quality improvement of biopharmaceuticals in China, and it is also playing an increasingly important role in the biopharmaceutical sector
.
In the future, as relevant pharmaceutical equipment companies continue to increase their investment in innovation and develop more high-quality, high-tech equipment, they will surely provide biopharmaceutical companies with more choices of mid-to-high-end equipment, and will also better assist China’s biopharmaceutical companies.
The pharmaceutical industry realizes commercial production and promotes the entire industry on the road of high-quality development
.